4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-021132
President and CEO sold 5,356 shares at an average $0.64 ($3,454)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-19 | Sale : show line 1 in the form 10b5-1 | −2,646 | $0.65 | $1,720 | 697,193 | D |
| 2023-07-20 | Sale : show line 2 in the form 10b5-1 | −2,710 | $0.64 | $1,734 | 694,483 | D |
| Open-market sales · 5,356 sh · avg $0.64 · $3,454 | ||||||
Loading xslF345X05/form4.xml…